![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | |
C07D 317/44 | |||
C07D 405/04 | |||
C07D 405/12 |
(11) | Number of the document | 2340252 |
(13) | Kind of document | T |
(96) | European patent application number | 09813307.7 |
Date of filing the European patent application | 2009-09-08 | |
(97) | Date of publication of the European application | 2011-07-06 |
(45) | Date of publication and mention of the grant of the patent | 2015-11-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/SE2009/050999 |
Date | 2009-09-08 |
(87) | Number | WO 2010/030224 |
Date | 2010-03-18 |
(30) | Number | Date | Country code |
95341 P | 2008-09-09 | US |
(72) |
AUFDENBLATTEN, Rhony, CH
BOHLIN, Martin, Hans, GB
HELLSTRÖM, Helena, GB
JOHANSSON, Peter, W, GB
LARSSON, Ulf, G, GB
RECKNAGEL, Mikaela, SE
WEISS, Ursula, heiress of WEISS Andreas (Deceased), CH
|
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
(54) | A PROCESS FOR PREPARING [1S- ]1-ALPHA, 2-ALPHA, 3-BETA (1S*, 2R*) 5-BETA] ]-3- [7- [2- (3, 4-DIF LUOROPHENYL) -CYCLOPROPYLAMINO]- 5- (PROPYLTHIO) -3H-1, 2, 3-TRIAZOLO [4, 5-D]PYRIMIDIN-3-YL]-5- (2- HYDROXYETHOXY) CYCLOPENTANE-1, 2-DIOL AND TO ITS INTERM |
A PROCESS FOR PREPARING [1S- ]1-ALPHA, 2-ALPHA, 3-BETA (1S*, 2R*) 5-BETA] ]-3- [7- [2- (3, 4-DIF LUOROPHENYL) -CYCLOPROPYLAMINO]- 5- (PROPYLTHIO) -3H-1, 2, 3-TRIAZOLO [4, 5-D]PYRIMIDIN-3-YL]-5- (2- HYDROXYETHOXY) CYCLOPENTANE-1, 2-DIOL AND TO ITS INTERM |